Drugs that Inhibit Mycolic Acid Biosynthesis in Mycobacterium tuberculosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|3|3|197-225

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.3, Iss.3, 2002-01, pp. : 197-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs that Inhibit Mycolic Acid Biosynthesis in Mycobacterium tuberculosis - An Update

By  

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 5, 2005-10 ,pp. : 393-413

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-01 ,pp. : 4357-4378

Bentham Science Publishers

Access to resources Recommend Favorite

Mycolic acids for the control of tuberculosis

By Sekanka Gianna   Baird Mark   innikin David   Grooten Johan  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 3, 2007-03 ,pp. : 315-331

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Hydrazide Agents to Inhibit Growth and Proliferation of Mycobacterium Tuberculosis

By  

Medicinal Chemistry, Vol. 8, Iss. 2, 2012-03 ,pp. : 273-280

Bentham Science Publishers

Access to resources Recommend Favorite

DFT Based QSAR/QSPR Models in the Development of Novel Anti-tuberculosis Drugs Targeting Mycobacterium tuberculosis

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-08 ,pp. : 4455-4473

Bentham Science Publishers

Access to resources Recommend Favorite